170 related articles for article (PubMed ID: 31154343)
21. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
[TBL] [Abstract][Full Text] [Related]
22. [A methotrexate-associated lympholiferative disorder patient with gastrointestinal perforation].
Aota Y; Nonaka T; Kimura S; Honda T; Okuda Y; Watanabe T; Fujiwara K; Yokoyama T; Wakabayashi Y; Sakurai M; Gotoh A
Nihon Ronen Igakkai Zasshi; 2017; 54(4):567-572. PubMed ID: 29213000
[TBL] [Abstract][Full Text] [Related]
23. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
[TBL] [Abstract][Full Text] [Related]
24. Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation.
Ross Y; Kamran M
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567235
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
26. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
27. Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder.
Pina-Oviedo S; Miranda RN; Medeiros LJ
Am J Surg Pathol; 2018 Jan; 42(1):116-129. PubMed ID: 29112013
[TBL] [Abstract][Full Text] [Related]
28. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
Kikuchi N; Uesugi M; Koda M; Shimizu T; Murakami K; Kono M; Tanaka H; Yamazaki M
J Neurosurg Spine; 2018 Nov; 29(5):545-548. PubMed ID: 30168781
[TBL] [Abstract][Full Text] [Related]
30. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.
Ureshino H; Kadota C; Kurogi K; Miyahara M; Kimura S
Intern Med; 2015; 54(17):2235-9. PubMed ID: 26328653
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Tokuhira M; Saito S; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Kimura Y; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M
Leuk Lymphoma; 2019 Oct; 60(10):2508-2515. PubMed ID: 30947579
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature.
Afonso C; Roque A; Almeida C; Pimentão MB; Julião MJ; Silva R; Geraldes C; Gomes M
Case Rep Hematol; 2022; 2022():7178065. PubMed ID: 35535243
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
Hashimoto K; Nagao T; Saito T; Kinoshita H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e1-5. PubMed ID: 24927637
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type.
Kohno K; Suzuki Y; Elsayed AA; Sakakibara A; Takahara T; Satou A; Kato S; Nakamura S; Asano N
Am J Clin Pathol; 2020 Apr; 153(5):571-582. PubMed ID: 31977037
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review.
Furudate K; Satake A; Narita N; Kobayashi W
J Oral Maxillofac Surg; 2018 Jan; 76(1):97-111. PubMed ID: 28654766
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T
Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912
[TBL] [Abstract][Full Text] [Related]
39. [A case of iatrogenic immunodeficiency-associated lymphoproliferative disease in a patient treated with methotrexate for rheumatoid arthritis for 9 consecutive years, which Showed natural remission after discontinuation of MTX therapy].
Kaneko J; Gozu K; Aoyagi H; Matsui T; Yoshida T; Hasegawa K; Isogai J; Maejima S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2454-6. PubMed ID: 24394142
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal.
Inui Y; Matsuoka H; Yakushijin K; Okamura A; Shimada T; Yano S; Takeuchi M; Ito M; Murayama T; Yamamoto K; Itoh T; Aiba K; Minami H
Leuk Lymphoma; 2015; 56(11):3045-51. PubMed ID: 25721751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]